Funding Details
- Awarder
- Inbox
- Date Award
- April 25, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$132,500,000
Company Info
- Company Description
- Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.
- Market
- Life-threatening diseases
- Location
-
San Diego,
CA,
USA
- Coinvestors
- Ally Bridge Group, Avidity Partners, AyurMaya, Eckuity, Fidelity Management & Research Company, Invus, Longitude Capital, Omega Funds, Perceptive Advisors, Piper Heartland Healthcare Capital, Silver Arch Bio, Symbiosis, T. Rowe Price Associates, Velosity Capital, Woodline Partners
Links